Full bill text rendering is coming soon.
In the meantime, read the full text on Congress.gov ↗.
Core Policy Mechanism Top 2
CDC Grants to States for Disease Surveillance
Authorizes the Centers for Disease Control and Prevention (CDC) to award grants to states to build systems that track the spread and prevalence of neglected diseases of poverty. Grants must prioritize geographic areas with the highest disease burden, as identified by the interagency task force. Authorizes the Centers for Disease Control and Prevention (CDC) to award grants to Federally Qualified Health Centers (FQHCs) to put clinical guidelines for neglected diseases of poverty into practice. Initial awards must prioritize FQHCs in areas with the highest disease prevalence or risk. Authorizes the National Institutes of Health (NIH) to fund Centers of Excellence at nonprofit research institutions to study, diagnose, prevent, and treat neglected diseases of poverty. Grants run up to five years and are renewable after peer review; eligible entities must have a demonstrated research track record in this area. Creates a formal federal task force to coordinate action on neglected diseases of poverty. The task force must develop a unified implementation plan, set measurable cross-agency goals, create clinical guidelines, and submit biannual recommendations to Congress on affordable prevention and treatment tools. Requires the Secretary of Health and Human Services (HHS) to develop and run educational programs about neglected diseases of poverty for two audiences: health care providers and public health professionals, and the general public, covering risk factors, symptoms, prevention, diagnosis, and treatment. Directs the Secretary of Health and Human Services (HHS) to fund or conduct research into affordable drugs, vaccines, diagnostics, and vector-control tools for neglected diseases of poverty, consistent with interagency task force recommendations. Research may be carried out directly or through grants and cooperative agreements.
- Population Scope High Approximately 12 million Americans may be affected by these diseases, with disproportionate burden on low-income and minority communities, and surveillance, clinical, research, and education programs collectively reach a very large share of the U.S. population across all states.
- Budgetary Magnitude Medium Multiple recurring discretionary grant programs are authorized — for state surveillance, FQHCs, Centers of Excellence, education, and research — but no dollar amounts are specified here; actual funding depends on future appropriations starting FY2027.
- Legal / Regulatory Depth High Creates multiple new statutory mandates — grant programs, a federal task force with binding duties, required clinical guidelines, and mandated biannual congressional reports — representing substantive additions to law rather than procedural adjustments.
- Degree of Discretion Granted Medium Core duties use mandatory 'shall' language (establish task force, award grants, develop guidelines), but the Secretary retains significant discretion over grant selection, prioritization criteria, and research scope.
- Implementation & Enforcement Burden Medium Standing up new surveillance systems, grant programs across multiple agency channels, a federal task force, Centers of Excellence, education programs, and an R&D portfolio imposes substantial ongoing administrative infrastructure without creating penalties or private enforcement rights.
- Temporal Commitment High The task force, grant programs, education mandates, and research authority have no expiry date and persist until Congress acts to repeal or modify them.
No signal yet
Funding / Appropriations Top 2
Open-Ended Appropriations Authorization Starting FY2027
Authorizes Congress to appropriate whatever funds are needed to carry out all programs in this bill, beginning in fiscal year 2027 with no end date. No specific dollar amount is set; actual funding levels will be determined by future appropriations legislation.
- Population Scope Medium Enables funding for all programs under the bill, which collectively serve millions of Americans in affected communities, but the authorization itself directly acts on federal agencies and appropriators rather than individuals.
- Budgetary Magnitude Medium Authorizes 'such sums as may be necessary' across multiple recurring programs with no dollar cap, creating an indefinite discretionary authorization baseline, though actual magnitude depends entirely on future appropriations.
- Legal / Regulatory Depth Low A 'such sums as may be necessary' authorization is a procedural predicate for future appropriations, not a substantive change to law — it creates no mandate, right, or obligation beyond enabling future funding.
- Degree of Discretion Granted High Congress retains full discretion over actual funding levels each fiscal year, and the open-ended 'such sums' formulation imposes no floor or ceiling on appropriators.
- Implementation & Enforcement Burden Low An appropriations authorization creates no enforcement mechanism, compliance requirement, or administrative burden; it is a passive legal predicate for future legislative action.
- Temporal Commitment High Runs from FY2027 through each subsequent fiscal year with no sunset, persisting indefinitely until Congress affirmatively repeals or modifies it.
No signal yet
No possible riders have been surfaced for this bill.
Summary
This bill directs the federal government to improve its response to neglected diseases of poverty — a group of infections such as Chagas disease, toxoplasmosis, and Dengue Fever that disproportionately affect low-income and minority communities in the United States. It creates new coordination, surveillance, education, and research programs aimed at closing gaps in how these diseases are tracked, treated, and prevented. Among other elements, the bill * creates an Interagency Task Force on Neglected Diseases of Poverty to coordinate federal agencies and issue recommendations to Congress; * funds state surveillance systems through the Centers for Disease Control and Prevention (CDC) to track where these diseases occur; * awards grants to Federally Qualified Health Centers (FQHCs) in high-risk areas to put clinical guidelines into practice; * supports public and provider education programs on risk factors, symptoms, and prevention; * funds research into new drugs, vaccines, and diagnostics for these diseases; * and establishes Centers of Excellence at nonprofit research institutions through the National Institutes of Health (NIH).
AI-generated summary, pending human review.
| Version | Event | Date | User support | Your vote | Roll calls |
|---|---|---|---|---|---|
| Original |
Initial publication
Sep 24, 2026
|
Sep 24, 2026 | No votes yet | — | — |
Log in or create an account to record your vote on this legislation. Results are visible to all visitors.
Core Policy Mechanism Top 2
CDC Grants to States for Disease Surveillance
Authorizes the Centers for Disease Control and Prevention (CDC) to award grants to states to build systems that track the spread and prevalence of neglected diseases of poverty. Grants must prioritize geographic areas with the highest disease burden, as identified by the interagency task force. Authorizes the Centers for Disease Control and Prevention (CDC) to award grants to Federally Qualified Health Centers (FQHCs) to put clinical guidelines for neglected diseases of poverty into practice. Initial awards must prioritize FQHCs in areas with the highest disease prevalence or risk. Authorizes the National Institutes of Health (NIH) to fund Centers of Excellence at nonprofit research institutions to study, diagnose, prevent, and treat neglected diseases of poverty. Grants run up to five years and are renewable after peer review; eligible entities must have a demonstrated research track record in this area. Creates a formal federal task force to coordinate action on neglected diseases of poverty. The task force must develop a unified implementation plan, set measurable cross-agency goals, create clinical guidelines, and submit biannual recommendations to Congress on affordable prevention and treatment tools. Requires the Secretary of Health and Human Services (HHS) to develop and run educational programs about neglected diseases of poverty for two audiences: health care providers and public health professionals, and the general public, covering risk factors, symptoms, prevention, diagnosis, and treatment. Directs the Secretary of Health and Human Services (HHS) to fund or conduct research into affordable drugs, vaccines, diagnostics, and vector-control tools for neglected diseases of poverty, consistent with interagency task force recommendations. Research may be carried out directly or through grants and cooperative agreements.
- Population Scope High Approximately 12 million Americans may be affected by these diseases, with disproportionate burden on low-income and minority communities, and surveillance, clinical, research, and education programs collectively reach a very large share of the U.S. population across all states.
- Budgetary Magnitude Medium Multiple recurring discretionary grant programs are authorized — for state surveillance, FQHCs, Centers of Excellence, education, and research — but no dollar amounts are specified here; actual funding depends on future appropriations starting FY2027.
- Legal / Regulatory Depth High Creates multiple new statutory mandates — grant programs, a federal task force with binding duties, required clinical guidelines, and mandated biannual congressional reports — representing substantive additions to law rather than procedural adjustments.
- Degree of Discretion Granted Medium Core duties use mandatory 'shall' language (establish task force, award grants, develop guidelines), but the Secretary retains significant discretion over grant selection, prioritization criteria, and research scope.
- Implementation & Enforcement Burden Medium Standing up new surveillance systems, grant programs across multiple agency channels, a federal task force, Centers of Excellence, education programs, and an R&D portfolio imposes substantial ongoing administrative infrastructure without creating penalties or private enforcement rights.
- Temporal Commitment High The task force, grant programs, education mandates, and research authority have no expiry date and persist until Congress acts to repeal or modify them.
No signal yet
Core Policy Mechanism
CDC Grants to States for Disease Surveillance
Funding / Appropriations Top 2
Open-Ended Appropriations Authorization Starting FY2027
Authorizes Congress to appropriate whatever funds are needed to carry out all programs in this bill, beginning in fiscal year 2027 with no end date. No specific dollar amount is set; actual funding levels will be determined by future appropriations legislation.
- Population Scope Medium Enables funding for all programs under the bill, which collectively serve millions of Americans in affected communities, but the authorization itself directly acts on federal agencies and appropriators rather than individuals.
- Budgetary Magnitude Medium Authorizes 'such sums as may be necessary' across multiple recurring programs with no dollar cap, creating an indefinite discretionary authorization baseline, though actual magnitude depends entirely on future appropriations.
- Legal / Regulatory Depth Low A 'such sums as may be necessary' authorization is a procedural predicate for future appropriations, not a substantive change to law — it creates no mandate, right, or obligation beyond enabling future funding.
- Degree of Discretion Granted High Congress retains full discretion over actual funding levels each fiscal year, and the open-ended 'such sums' formulation imposes no floor or ceiling on appropriators.
- Implementation & Enforcement Burden Low An appropriations authorization creates no enforcement mechanism, compliance requirement, or administrative burden; it is a passive legal predicate for future legislative action.
- Temporal Commitment High Runs from FY2027 through each subsequent fiscal year with no sunset, persisting indefinitely until Congress affirmatively repeals or modifies it.
No signal yet
Funding / Appropriations
Open-Ended Appropriations Authorization Starting FY2027
Incomplete vote
You have not made a selection on all required items:
Choose Neutral if you prefer not to commit. Leaving without completing will remove all your votes for this bill from the totals.
Maximum recommendations reached
You have already recommended the maximum number of components allowed on this bill. To recommend [new component], choose one of your current recommendations to unselect: